Excess Body Weight and Gallstone Disease

Overview

Journal Visc Med

Date 2021 Sep 20

PMID 34540940

Citations 8

Authors

Caroline Sarah Stokes

Frank Lammert

Affiliations

Soon will be listed here.

Abstract

Background: Approximately one fifth of adults are diagnosed with gallstones worldwide. Of these, around 25% develop gallstone disease (indicated by the presence of symptoms) and undergo cholecystectomy.

Summary: The risk of gallstones is influenced by a combination of genetic and lifestyle factors, such as excess body weight. In fact, body mass has been demonstrated to be a major risk factor for symptomatic gallstones. Rapid weight loss can also initiate a prolithogenic state and further increase the likelihood of either gallstone formation or existing gallstones becoming symptomatic; however, sensible weight loss strategies can mitigate this risk. This review discusses the role of excess body weight and the risk of gallstone disease, as well as the options available for the prevention of symptomatic gallstones.

Key Messages: Healthy weight loss diets combined with regular physical activity can promote successful weight loss and weight maintenance and reduce the risk of gallstones. Should rapid weight loss be required for health reasons or be expected, e.g., after bariatric surgery, prophylactic ursodeoxycholic acid during the period of weight reduction has been demonstrated to reduce the incidence of gallstones formation or symptomatic gallstone occurrence. The recent German guidelines on gallstones recommend simultaneous cholecystectomy during bariatric surgery but only for those with preexisting symptomatic stones.

Citing Articles

Effect of comprehensive perioperative nursing on pain intensity, complication rates, and comfort levels in patients undergoing gallstone surgery.

Bao C, Ding X, Qi Q, Ye P, Fang Z World J Gastrointest Surg. 2025; 17(2):99826.

PMID: 40061965 PMC: 11885992. DOI: 10.4240/wjgs.v17.i2.99826.

Long-term weight patterns and physical activity in gallstones.

Kim H, Kang T, Kim M, Swan H, Park S Sci Rep. 2024; 14(1):25817.

PMID: 39468292 PMC: 11519584. DOI: 10.1038/s41598-024-77218-8.

Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group.

Janez A, Muzurovic E, Bogdanski P, Czupryniak L, Fabryova L, Fras Z Diabetes Ther. 2024; 15(9):1865-1892.

PMID: 38990471 PMC: 11330437. DOI: 10.1007/s13300-024-01615-5.

[Establishment and Validation of a Predictive Model for Gallstone Disease in the General Population: A Multicenter Study].

Yu W, Xia J, Chen F, Jiao P, Cui P, Zhang C Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 55(3):641-652.

PMID: 38948266 PMC: 11211771. DOI: 10.12182/20240560501.

Adipocentric origin of the common cardiometabolic complications of obesity in the young up to the very old: pathophysiology and new therapeutic opportunities.

Sarzani R, Landolfo M, Di Pentima C, Ortensi B, Falcioni P, Sabbatini L Front Med (Lausanne). 2024; 11:1365183.

PMID: 38654832 PMC: 11037084. DOI: 10.3389/fmed.2024.1365183.

References

Su P, Hsu Y, Cheng Y, Kor C, Su W . Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years. BMC Gastroenterol. 2019; 19(1):117. PMC: 6610843. DOI: 10.1186/s12876-019-1032-y. View

Li V, Pulido N, Fajnwaks P, Szomstein S, Rosenthal R, Martinez-Duartez P . Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc. 2008; 23(7):1640-4. DOI: 10.1007/s00464-008-0204-6. View

Festi D, Colecchia A, Orsini M, Sangermano A, Sottili S, Simoni P . Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well). Int J Obes Relat Metab Disord. 1998; 22(6):592-600. DOI: 10.1038/sj.ijo.0800634. View

Tsai C, Leitzmann M, Willett W, Giovannucci E . Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr. 2004; 80(1):38-44. DOI: 10.1093/ajcn/80.1.38. View

Kim J, Schirmer B . Safety and efficacy of simultaneous cholecystectomy at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009; 5(1):48-53. DOI: 10.1016/j.soard.2008.06.001. View

Di Ciaula A, Wang D, Portincasa P . Gallbladder and gastric motility in obese newborns, pre-adolescents and adults. J Gastroenterol Hepatol. 2012; 27(8):1298-305. DOI: 10.1111/j.1440-1746.2012.07149.x. View

Adams L, Chang C, Pope J, Kim Y, Liu P, Yates A . Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy. Obes Surg. 2015; 26(5):990-4. DOI: 10.1007/s11695-015-1858-5. View

Gutt C, Jenssen C, Barreiros A, Gotze T, Stokes C, Jansen P . [Updated S3-Guideline for Prophylaxis, Diagnosis and Treatment of Gallstones. German Society for Digestive and Metabolic Diseases (DGVS) and German Society for Surgery of the Alimentary Tract (DGAV) - AWMF Registry 021/008]. Z Gastroenterol. 2018; 56(8):912-966. DOI: 10.1055/a-0644-2972. View

Cozma A, Orasan O, Sampelean D, Fodor A, Vlad C, Negrean V . Endothelial dysfunction in metabolic syndrome. Rom J Intern Med. 2010; 47(2):133-40. View

10.

Reeves J, Burton B, Broderick R, Waterman R, Gabriel R . Obesity and unanticipated hospital admission following outpatient laparoscopic cholecystectomy. Surg Endosc. 2020; 35(3):1348-1354. DOI: 10.1007/s00464-020-07514-7. View

11.

Kalle Kwaifa I, Bahari H, Yong Y, Md Noor S . Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications. Biomolecules. 2020; 10(2). PMC: 7072669. DOI: 10.3390/biom10020291. View

12.

Wudel Jr L, Wright J, Debelak J, Allos T, Shyr Y, Chapman W . Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res. 2002; 102(1):50-6. DOI: 10.1006/jsre.2001.6322. View

13.

Shiffman M, Sugerman H, Kellum J, Brewer W, Moore E . Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility. Int J Obes Relat Metab Disord. 1993; 17(3):153-8. View

14.

Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P, Marschall H . Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology. 2005; 41(5):1138-43. DOI: 10.1002/hep.20654. View

15.

Moran S, Milke P, Rodriguez-Leal G, Uribe M . Ref: Gallstone formation in obese subjects undergoing a weight reduction diet. Int J Obes Relat Metab Disord. 1998; 22(3):282-4. DOI: 10.1038/sj.ijo.0800588. View

16.

Tsai C, Leitzmann M, Willett W, Giovannucci E . Long-chain saturated fatty acids consumption and risk of gallstone disease among men. Ann Surg. 2007; 247(1):95-103. DOI: 10.1097/SLA.0b013e31815792c2. View

17.

Berr F, Holl J, Jungst D, Fischer S, Richter W, Seifferth B . Dietary N-3 polyunsaturated fatty acids decrease biliary cholesterol saturation in gallstone disease. Hepatology. 1992; 16(4):960-7. DOI: 10.1002/hep.1840160418. View

18.

Nakeeb A, Comuzzie A, Al-Azzawi H, Sonnenberg G, Kissebah A, Pitt H . Insulin resistance causes human gallbladder dysmotility. J Gastrointest Surg. 2006; 10(7):940-8. DOI: 10.1016/j.gassur.2006.04.005. View

19.

Villegas L, Schneider B, Provost D, Chang C, Scott D, Sims T . Is routine cholecystectomy required during laparoscopic gastric bypass?. Obes Surg. 2004; 14(2):206-11. DOI: 10.1381/096089204322857573. View

20.

Weinsier R, Wilson L, Lee J . Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med. 1995; 98(2):115-7. DOI: 10.1016/S0002-9343(99)80394-5. View